tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2616 Stock Latest News

CStone Pharmaceuticals Completes HK$467.28 Million Share Placing to Boost R&D
Company AnnouncementsCStone Pharmaceuticals Completes HK$467.28 Million Share Placing to Boost R&D
1d ago
2616
CStone Pharmaceuticals Secures NMPA Approval for Local Manufacturing of GAVRETO® in China
PremiumCompany Announcements
CStone Pharmaceuticals Secures NMPA Approval for Local Manufacturing of GAVRETO® in China
8d ago
2616
CStone Pharmaceuticals Announces Share Placement to Raise HK$467 Million
PremiumCompany Announcements
CStone Pharmaceuticals Announces Share Placement to Raise HK$467 Million
9d ago
2616
CStone Pharmaceuticals Partners with Istituto Gentili to Expand Sugemalimab’s Reach in Europe
PremiumCompany Announcements
CStone Pharmaceuticals Partners with Istituto Gentili to Expand Sugemalimab’s Reach in Europe
10d ago
2616
CStone Pharmaceuticals Advances Clinical Trials for Innovative Cancer Therapy
PremiumCompany Announcements
CStone Pharmaceuticals Advances Clinical Trials for Innovative Cancer Therapy
11d ago
2616
CStone Pharmaceuticals Updates Phase III Study on Nofazinlimab for Liver Cancer
PremiumCompany AnnouncementsCStone Pharmaceuticals Updates Phase III Study on Nofazinlimab for Liver Cancer
13d ago
2616
CStone Pharmaceuticals Unveils Promising Bispecific Antibody Targets for Autoimmune Diseases
Premium
Company Announcements
CStone Pharmaceuticals Unveils Promising Bispecific Antibody Targets for Autoimmune Diseases
15d ago
2616
CStone Pharmaceuticals Passes Key Resolutions at AGM
Premium
Company Announcements
CStone Pharmaceuticals Passes Key Resolutions at AGM
22d ago
2616
CStone Pharmaceuticals Announces Board of Directors Composition
PremiumCompany Announcements
CStone Pharmaceuticals Announces Board of Directors Composition
22d ago
2616
CStone Pharmaceuticals Strengthens Governance with New Nomination Committee
PremiumCompany Announcements
CStone Pharmaceuticals Strengthens Governance with New Nomination Committee
22d ago
2616
CStone’s Sugemalimab Shows Promising Long-Term Survival in NSCLC Trial
PremiumCompany Announcements
CStone’s Sugemalimab Shows Promising Long-Term Survival in NSCLC Trial
29d ago
2616
CStone Pharmaceuticals Addresses Criticism of Independent Director
PremiumCompany Announcements
CStone Pharmaceuticals Addresses Criticism of Independent Director
1M ago
2616
CStone Pharmaceuticals Announces 2025 AGM and Key Resolutions
PremiumCompany AnnouncementsCStone Pharmaceuticals Announces 2025 AGM and Key Resolutions
1M ago
2616
CStone Pharmaceuticals Unveils Promising Cancer Therapies at AACR 2025
Premium
Company Announcements
CStone Pharmaceuticals Unveils Promising Cancer Therapies at AACR 2025
2M ago
2616
CStone Pharmaceuticals Grants RSUs and Share Options to Key Personnel
Premium
Company Announcements
CStone Pharmaceuticals Grants RSUs and Share Options to Key Personnel
3M ago
2616
CStone Pharmaceuticals Completes Successful Share Placement
PremiumCompany Announcements
CStone Pharmaceuticals Completes Successful Share Placement
3M ago
2616
CStone CEO Increases Shareholding, Signaling Confidence in Company’s Future
PremiumCompany Announcements
CStone CEO Increases Shareholding, Signaling Confidence in Company’s Future
3M ago
2616
CStone Pharmaceuticals Announces HK$234.64 Million Share Placement
PremiumCompany Announcements
CStone Pharmaceuticals Announces HK$234.64 Million Share Placement
4M ago
2616
CStone Pharmaceuticals Reports 2024 Financial Results with Reduced Losses
PremiumCompany Announcements
CStone Pharmaceuticals Reports 2024 Financial Results with Reduced Losses
4M ago
2616
CStone Pharmaceuticals to Present Innovative Cancer Therapies at AACR 2025
PremiumCompany AnnouncementsCStone Pharmaceuticals to Present Innovative Cancer Therapies at AACR 2025
4M ago
2616
CStone Pharmaceuticals Seeks EMA Approval for Sugemalimab in Stage III NSCLC
Premium
Company Announcements
CStone Pharmaceuticals Seeks EMA Approval for Sugemalimab in Stage III NSCLC
4M ago
2616
CStone Pharmaceuticals Schedules Board Meeting to Approve 2024 Annual Results
Premium
Company Announcements
CStone Pharmaceuticals Schedules Board Meeting to Approve 2024 Annual Results
4M ago
2616

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >